Integration of Multi‐Rotor and Multi‐Conjugation: Ultrahigh Absorption Coefficient Dye Enables NIR‐II Fluorescence Imaging‐guided Photothermal Immunotherapy
The progressive accumulation of mutated genes in cancer cells facilitates tumor immune escape. Photothermal immunotherapy addresses this problem by triggering immunogenic cell death (ICD) through photothermal treatment, releasing endogenous immunogenic neoantigens. Herein, guided by the "multi-rotor & multi-conjugation" concept, near-infrared region II (NIR-II) cyanine molecules are designed with varying numbers of benzene rotors. TPE-CyA, with more benzene rotors, features an ultra-high molar extinction coefficient (1.786 × 10<sup>5</sup> m<sup>-1</sup> cm<sup>-1</sup>), a well-balanced fluorescence quantum yield (0.99%), and a 45.72% photothermal conversion efficiency. TPE-CyA nanoparticles (TPE-CyA NPs) are ideal for high-resolution NIR-II fluorescence imaging and angiography. Imaging-guided TPE-CyA NPs show great potential in NIR-II photothermal immunotherapy by effectively suppressing bilateral tumor growth and liver metastasis without additional immunoadjuvants. Moreover, the photothermal immunotherapy guided by TPE-CyA NPs can induce ICD, promote dendritic cell (DCs) maturation, increase T-cell infiltration in tumors, and activate systemic immunity to prevent metastasis and recurrence. This research highlights the potential of NIR-II photothermal therapy in tumor cell ablation, immune activation for cancer and vascular diagnostics, presenting a novel strategy for both primary and metastatic cancers.
Authors
- Jiapeng Dong (ORCID: https://orcid.org/0009-0004-0894-8776)
- Hui Xie (ORCID: https://orcid.org/0000-0002-7179-4843)
- Guining Cao
- Qin Q (ORCID: https://orcid.org/0000-0001-6709-7132)
- Jiajing Tang (ORCID: https://orcid.org/0000-0001-9928-7918)
- Huiling Ye (ORCID: https://orcid.org/0009-0004-5196-0420)
- Yaoxun Zeng
- Mingliang Deng (ORCID: https://orcid.org/0000-0001-6030-9331)
- Zhenxing Pan
- Xujie Liu (ORCID: https://orcid.org/0000-0001-8713-4287)
- Xiang Su (ORCID: https://orcid.org/0000-0002-6346-7666)
- Yan He (ORCID: https://orcid.org/0000-0001-7133-0558)
- Jiacheng Tang
- Hailiang Zhang (ORCID: https://orcid.org/0000-0002-3737-1046)
- Xin Cheng (ORCID: https://orcid.org/0009-0006-4152-8313)
- Meng Wang (ORCID: https://orcid.org/0000-0003-4067-1127)
Institutions
- Sun Yat-sen University (CN)
- Guangdong Pharmaceutical University (CN)
- Sun Yat-sen University Cancer Center (CN)
- Yunnan University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Small
- Published
- 2025-08-21
- DOI
- https://doi.org/10.1002/smll.202508447
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67
Funders
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province